Shah M, Chen TY, Ison G, Fiero MH, et al. Overall Survival and the Evolving Benefit-Risk Assessment for Poly (ADP-ribose) Polymerase Inhibitors in Advanced Ovarian Cancer. J Clin Oncol 2025 May 19:JCO2402834. doi: 10.1200/JCO-24-02834.
PMID: 40388682